In vitro stimulation of renal tubular p-aminohippurate transport by dexamethasone in rat kidneys and in intact kidney tissue of patients suffering from renal cell carcinoma

被引:4
作者
Fleck, C [1 ]
Kratochwil, E
Winterstein, K
Gockeritz, S
Schubert, J
机构
[1] Klinikum Friedrich Schiller Univ Jena, Inst Pharmakol & Toxikol, D-07740 Jena, Germany
[2] Univ Jena, Dept Urol, D-6900 Jena, Germany
来源
UROLOGICAL RESEARCH | 1998年 / 26卷 / 02期
关键词
renal tubular transport; p-aminohippurate; stimulation; renal cell carcinoma; dexamethasone; triiodothyronine;
D O I
10.1007/s002400050037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to test whether or not the accumulation of p-aminohippurate (PAH) can be increased in intact human renal cortical slices obtained from tumor-bearing kidneys of patients suffering from renal cell carcinoma (RCC). Tissue slices were incubated for 24 h in Williams medium E containing 0.01-50 mu M dexamethasone. Thereafter slices were placed in PAM-containing Cross-Taggart medium and PAH uptake into kidney tissue was measured for 2 h. In both rat and human renal tissue slices, PAH uptake capacity increased significantly in a concentration-dependent manner after 24 h of incubation in dexamethasone-containing medium (rat, 136%; man, 156%). The stimulatory effect was already significant after 12 h of incubation. In additional experiments it was shown that incubation in triiodothyronine (T-3)-containing medium has different effects: in man, T-3 does not influence the PAH accumulation capacity of renal cortical slices whereas in rats PAH accumulation is significantly lower after 24 h of incubation with T-3 Thus stimulation of tubular transport capacity can be performed in vitro in human renal cortical slices. Discrepancies between the effects of dexamethasone and T-3 indicate different modes of action of the two hormones at the cellular level.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 41 条
[1]   A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma [J].
Amato, R ;
Meyers, C ;
Ellerhorst, J ;
Finn, L ;
Kilbourn, R ;
Sella, A ;
Logothetis, C .
ANNALS OF ONCOLOGY, 1995, 6 (09) :911-914
[2]   P-glycoproteins and multidrug resistance [J].
Bellamy, WT .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :161-183
[3]  
BERKHIN EB, 1975, P ACAD SCI USSR, V220, P1463
[4]   P-glycoprotein multidrug resistance and cancer [J].
Bosch, I ;
Croop, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (02) :F37-F54
[5]  
Bratton AC, 1939, J BIOL CHEM, V128, P537
[6]   EXCRETION OF DRUGS DURING POSTNATAL-DEVELOPMENT [J].
BRAUNLICH, H .
PHARMACOLOGY & THERAPEUTICS, 1981, 12 (02) :299-320
[7]  
BRAUNLICH H, 1986, MED BIOL, V64, P267
[8]  
BRAUNLICH H, 1983, PHARMAZIE, V38, P483
[9]  
BRAUNLICH H, 1988, PEDIATR NEPHROL, V2, P151
[10]  
BRAUNLICH H, 1987, PHARMAZIE, V42, P846